PDGFRα+ 纤维细胞除加剧了室内灰尘引发过敏性喘模型中的病理特征
相关实验视频
Updated: Jan 13, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
Ha Eun Shin1, Sanyeowool An2, Jack Heckl3
1Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
Disease models & mechanisms
|October 28, 2025
概括
失去特定的肺纤维细胞 (PDGFRα+) 会破坏免疫平衡,恶化喘症状,如粘液产生和炎症. 这凸显了它们在维持肺部健康方面发挥的关键作用.
科学领域:
- 肺免疫学 肺免疫学
- 细胞生物学 细胞生物学
- 呼吸系统药物 呼吸系统药物
背景情况:
- 喘是一种慢性呼吸道炎症疾病,对全球健康产生重大影响.
- 纤维细胞是组织修复和纤维化中的关键,使他们成为喘潜在的治疗点.
- 纤维细胞在喘发育和进展中的确切作用尚未完全理解.
研究的目的:
- 为了研究PDGFRα+纤维细胞枯竭对肺部恒温的影响.
- 确定PDGFRα+纤维细胞损失对喘发育和发病的后果.
主要方法:
- 使用转基因小鼠模型,专门切除PDGFRα+纤维细胞.
- 评估肺组织和支气管膜洗液的细胞组成和基因表达.
- 在控制和纤维细胞被剥离的小鼠中诱导喘,以评估疾病的严重程度.
主要成果:
- 成功并持续地切除PDGFRα+纤维细胞 (减少75-85%).
- 稳定状态的肺部显示了减少的脂纤维细胞,改变的细胞外基因矩阵基因和增加的中性粒细胞.
- 在被切除的小鼠中诱导喘导致了质产生的加剧,中性粒细胞的激活,以及增多的炎症细胞 (巨细胞,乙氨基粒细胞).
结论:
- PDGFRα+纤维细胞对于维持肺免疫恒温是必不可少的.
- 丢失PDGFRα+纤维细胞会破坏气道免疫细胞的组成,促进气道重塑.
- 这些变化对喘的发病有很大影响.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K

